These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 29129827

  • 1. Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Weng LC, Preis SR, Hulme OL, Larson MG, Choi SH, Wang B, Trinquart L, McManus DD, Staerk L, Lin H, Lunetta KL, Ellinor PT, Benjamin EJ, Lubitz SA.
    Circulation; 2018 Mar 06; 137(10):1027-1038. PubMed ID: 29129827
    [Abstract] [Full Text] [Related]

  • 2. Associations of risk factor burden and genetic predisposition with the 10-year risk of atrial fibrillation: observations from a large prospective study of 348,904 participants.
    Zhang J, Chen G, Wang C, Wang X, Qian ZM, Cai M, Vaughn MG, Bingheim E, Li H, Gao Y, Lip GYH, Lin H.
    BMC Med; 2023 Mar 08; 21(1):88. PubMed ID: 36882748
    [Abstract] [Full Text] [Related]

  • 3. Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study.
    Rahman F, Yin X, Larson MG, Ellinor PT, Lubitz SA, Vasan RS, McManus DD, Magnani JW, Benjamin EJ.
    Hypertension; 2016 Sep 08; 68(3):597-605. PubMed ID: 27512109
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Dewland TA, Soliman EZ, Yamal JM, Davis BR, Alonso A, Albert CM, Simpson LM, Haywood LJ, Marcus GM.
    Circ Arrhythm Electrophysiol; 2017 Dec 08; 10(12):. PubMed ID: 29212812
    [Abstract] [Full Text] [Related]

  • 5. White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study).
    Rienstra M, Sun JX, Magnani JW, Sinner MF, Lubitz SA, Sullivan LM, Ellinor PT, Benjamin EJ.
    Am J Cardiol; 2012 Feb 15; 109(4):533-7. PubMed ID: 22100030
    [Abstract] [Full Text] [Related]

  • 6. Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study.
    Hobbelt AH, Siland JE, Geelhoed B, Van Der Harst P, Hillege HL, Van Gelder IC, Rienstra M.
    Europace; 2017 Feb 01; 19(2):226-232. PubMed ID: 28175276
    [Abstract] [Full Text] [Related]

  • 7. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
    Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ.
    Circulation; 2004 Aug 31; 110(9):1042-6. PubMed ID: 15313941
    [Abstract] [Full Text] [Related]

  • 8. Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study.
    Staerk L, Wang B, Lunetta KL, Helm RH, Ko D, Sherer JA, Ellinor PT, Lubitz SA, McManus DD, Vasan RS, Benjamin EJ, Trinquart L.
    J Am Heart Assoc; 2017 Nov 14; 6(11):. PubMed ID: 29138179
    [Abstract] [Full Text] [Related]

  • 9. Atrial fibrillation and the risk of myocardial infarction.
    Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M.
    JAMA Intern Med; 2014 Jan 14; 174(1):107-14. PubMed ID: 24190540
    [Abstract] [Full Text] [Related]

  • 10. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
    Staerk L, Wang B, Preis SR, Larson MG, Lubitz SA, Ellinor PT, McManus DD, Ko D, Weng LC, Lunetta KL, Frost L, Benjamin EJ, Trinquart L.
    BMJ; 2018 Apr 26; 361():k1453. PubMed ID: 29699974
    [Abstract] [Full Text] [Related]

  • 11. Associations Between Alcohol Intake and Genetic Predisposition With Atrial Fibrillation Risk in a National Biobank.
    Halford JL, Weng LC, Choi SH, Jurgens SJ, Morrill VN, Khurshid S, Trinquart L, Benjamin EJ, Ellinor PT, Lubitz SA.
    Circ Genom Precis Med; 2020 Dec 26; 13(6):e003111. PubMed ID: 33156697
    [Abstract] [Full Text] [Related]

  • 12. Relation of Functional Status to Risk of Development of Atrial Fibrillation.
    Ramkumar S, Yang H, Wang Y, Nolan M, Negishi K, Sanders P, Marwick TH.
    Am J Cardiol; 2017 Feb 15; 119(4):572-578. PubMed ID: 27956001
    [Abstract] [Full Text] [Related]

  • 13. Pulse pressure and risk of new-onset atrial fibrillation.
    Mitchell GF, Vasan RS, Keyes MJ, Parise H, Wang TJ, Larson MG, D'Agostino RB, Kannel WB, Levy D, Benjamin EJ.
    JAMA; 2007 Feb 21; 297(7):709-15. PubMed ID: 17312290
    [Abstract] [Full Text] [Related]

  • 14. Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation.
    Hyman MC, Levin MG, Gill D, Walker VM, Georgakis MK, Davies NM, Marchlinski FE, Damrauer SM.
    Hypertension; 2021 Feb 21; 77(2):376-382. PubMed ID: 33390040
    [Abstract] [Full Text] [Related]

  • 15. Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort.
    Staerk L, Preis SR, Lin H, Casas JP, Lunetta K, Weng LC, Anderson CD, Ellinor PT, Lubitz SA, Benjamin EJ, Trinquart L.
    Circ Cardiovasc Qual Outcomes; 2020 Apr 21; 13(4):e005918. PubMed ID: 32228064
    [Abstract] [Full Text] [Related]

  • 16. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.
    Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ.
    J Am Heart Assoc; 2013 Mar 18; 2(2):e000102. PubMed ID: 23537808
    [Abstract] [Full Text] [Related]

  • 17. Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.
    Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Julius S, Dahlöf B, Devereux RB.
    Am J Hypertens; 2014 Jul 18; 27(7):966-72. PubMed ID: 24552888
    [Abstract] [Full Text] [Related]

  • 18. Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.
    Soliman EZ, Lopez F, O'Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, Cushman M, Alonso A.
    Circulation; 2015 May 26; 131(21):1843-50. PubMed ID: 25918127
    [Abstract] [Full Text] [Related]

  • 19. The association between eicosanoids and incident atrial fibrillation in the Framingham Heart Study.
    Kornej J, Qadan MA, Alotaibi M, Van Wagoner DR, Watrous JD, Trinquart L, Preis SR, Ko D, Jain M, Benjamin EJ, Cheng S, Lin H.
    Sci Rep; 2022 Nov 23; 12(1):20218. PubMed ID: 36418854
    [Abstract] [Full Text] [Related]

  • 20. Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke.
    Tada H, Shiffman D, Smith JG, Sjögren M, Lubitz SA, Ellinor PT, Louie JZ, Catanese JJ, Engström G, Devlin JJ, Kathiresan S, Melander O.
    Stroke; 2014 Oct 23; 45(10):2856-2862. PubMed ID: 25123217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.